Regulatory Aspects of Nanomaterials: Current and Future Perspective

Nanotechnology and its applications have been a rapidly growing area of research in the previous two decades. In the domain of pharmaceutical research, nanotechnology is applied in the study and preparation of nano-size range materials ranging from 1-100nm. Nanoparticulate medications or nano drug delivery systems are not a novel concept, but they are a rapidly evolving nanoscience. In nanomedicine, nanoscale materials are used to develop diagnostic tools or to deliver active substances to a particular place in a consistent and controlled manner. Nanoparticles have groveled in many different forms, including liposomes, niosomes, solid lipid nanoparticles, emulsions, suspension nanocrystals, micelles, and dendrimers. When compared to pure drugs or other conventional formulations, these all have improved medication efficacy or therapeutic effect. Nanoparticles are being employed in a variety of fields, including cosmetics. However, as nanotechnology progressed, numerous controversies arise concerning nanoparticles. Consumer safety, as well as environmental repercussions, must be regulated. Nanotechnology has life-changing applications, yet nanoparticle regulation has been inconsistent and insufficient. Failure in biotechnology regulation in recent years has resulted in several negative consequences for the environment and human health. This article aims to raise knowledge about the importance of regulatory frameworks for nanotechnology and nanoparticles.